AXGN
Axogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$49.37
−0.52%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $0.14
- Revenue estimate
- $83.3M
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $0.21
- EPS estimate
- $0.13
- Revenue actual
- $75.8M
- Revenue estimate
- $73.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -108.3%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $57
- PT range
- $52 – $60
- Analysts
- 8
8 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $0.13 | $0.21 | Beat 59.94% | $75.8M |
| Jul 29, 2026 | $0.12 | $0.12 | Miss -1.15% | $69.7M |
| Apr 28, 2026 | $0.12 | $0.07 | Miss -41.67% | $61.5M |
| Feb 24, 2026 | $0.08 | -$0.28 | Miss -450.43% | $59.9M |
| Oct 29, 2025 | $0.09 | $0.12 | Beat 33.33% | $60.1M |
| May 8, 2025 | -$0.01 | -$0.02 | Miss -100.00% | $48.6M |
| Feb 25, 2025 | $0.04 | $0.08 | Beat 100.00% | $49.4M |
| Nov 7, 2024 | $0.01 | $0.07 | Beat 1066.67% | $48.6M |
| Aug 8, 2024 | -$0.05 | $0.05 | Beat 200.00% | $47.9M |
| May 2, 2024 | -$0.10 | -$0.06 | Beat 40.00% | $41.4M |
| Mar 5, 2024 | -$0.09 | -$0.06 | Beat 33.33% | $42.9M |
| Mar 14, 2023 | -$0.10 | -$0.03 | Beat 70.00% | $36.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027